Replies to post #179 on Makism 3D Corp. (fka MDDD)

[Daenerys]

It is funny to watch shorters squirm on these boards. :)
In the SEC filings, the companies are required to warn the investors of any forseeable risks, even improbable ones. It is standard practice, I'm sure you know that if you read any other companies filings.
For example, here is the risk factors from Twitter's S1 filing:
Twitter has submitted its filing to the U.S. Securities and Exchange Commission (SEC) listing potential risks to the business across several different areas. In this series, we look at each of these risks in turn and what this means for anyone planning to invest in the company.

From the Twitter's filing :

"In making your investment decision, you should understand that we and the underwriters have not authorized any other party to provide you with information concerning us or this offering."

"We may invest or spend the proceeds of this offering in ways with which you may not agree or in ways which may not yield a return."

"Purchasers in this offering will experience immediate and substantial dilution in the book value of their investment."

"If securities or industry analysts do not publish or cease publishing research or reports about us, our business or our market, or if they change their recommendations regarding our common stock adversely, the price of our common stock and trading volume could decline."

"We do not expect to declare any dividends in the foreseeable future."

"Prior to this offering, there has been limited trading of our common stock at prices that may be higher than what our common stock will trade at once it is listed."

"The market price of our common stock may be volatile, and you could lose all or part of your investment."

"A total of [unknown] or [unknown], of our outstanding shares of our common stock after this offering will be restricted from immediate resale, but may be sold on a stock exchange in the near future. The large number of shares eligible for public sale or subject to rights requiring us to register them for public sale could depress the market price of our common stock."

"We have incurred significant operating losses in the past, and we may not be able to achieve or subsequently maintain profitability."

"We are an emerging growth company, and any decision on our part to comply only with certain reduced reporting and disclosure requirements applicable to emerging growth companies could make our common stock less attractive to investors."

[BiotechValues]

Quite a bit less than $65Mmarket cap now. My guess is it's at/near the bottom.